A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

NCT05339802 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Infection

Interventions

COMBINATION_PRODUCT: 9MW1411 injection 1 combined with Linezolid
COMBINATION_PRODUCT: 9MW1411 injection 2 combined with Linezolid
COMBINATION_PRODUCT: 9MW1411 injection placebo combined with Linezolid

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.